|
|
||||||||
|
FIGURE 3. Five-year survival of 80 patients with AL amyloidosis. (A) Patients with (dotted line) and without (solid line) clinical involvement of heart. (B) Patients with high (>50%) () and with low (<50%) (
) EVR24. (C) Patients stratified according to high (>50%) () and low (<50%) (
) EVR24 and presence (dotted line) or absence (solid line) of clinical involvement of heart.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |